Prevention of cisplatin nephrotoxicity
Cisplatin has a well-established role in the treatment of broad spectrum of malignancies; however its use is limited because of cisplatin-induced nephrotoxicity (CIN) which can be progressive in more than 50% of cases. The most important risk factors for CIN include higher doses of cisplatin, previo...
Saved in:
Main Authors: | Hayati Fatemeh (Author), Hossainzadeh Mehran (Author), Shayanpour Shokouh (Author), Abedi-Gheshlaghi Zahra (Author), Beladi Mousavi Seyed Seifollah (Author) |
---|---|
Format: | Book |
Published: |
Society of Diabetic Nephropathy Prevention,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The relationship between chronic kidney disease and cancer
by: Seyed Majid Mousavi Movahhed, et al.
Published: (2018) -
Comparison of clinical outcome of induction immunosuppressive therapy with thymoglobulin and standard therapy in kidney transplantation; a randomized double-blind clinical trial
by: Heshmatollah Shahbazian, et al.
Published: (2020) -
The effect of the omega-3 supplement on uremic pruritus in hemodialysis patients; a double-blind randomized controlled clinical trial
by: Shokouh Shayanpour, et al.
Published: (2019) -
Melatonin in the prevention of cisplatin-induced acute nephrotoxicity: a randomized, controlled clinical trial
by: Sara Karvan, et al.
Published: (2022) -
Dose kidney transplant nephrectomy stop disease progression in plasma exchange resistant post transplant hemolytic uremic syndrome? A case report
by: Farzaneh Sharifipour, et al.
Published: (2013)